Fundamental dimension Equity attribute | AERLeader $145.92▼-1.19% Cap $22.94BP/E 7.1x QuantScore62/100 | ASLEPeer $4.67▼-0.64% Cap $222.9MP/E -90.7x QuantScore39/100 | BCVVFPeer $8.360.00% Cap $5.80BP/E 7.7x QuantScore40/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
95/100 |
15/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 69/100 | 64/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 37/100 | 34/100 |
Growth Revenue / earnings growth & margins | 47/100 | 23/100 | 39/100 |
Sentiment Analyst ratings, targets & revisions | 71/100 | 50/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 7.1x | -90.7x | 7.7x |
Forward P/E (next FY) | 7.7x | 30.1x | 7.2x |
EV / EBITDA (TTM) | 7.8x | 15.4x | 10.5x |
Price / Sales | 2.8x | 0.7x | 2.6x |
Price / Free Cash Flow | -74.6x | -5.7x | -2.4x |
PEG ratio | 0.28 | 0.66 | -8.98 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 1 / 9 | 6 / 9 |
Altman Z-Score | 0.95 (Distress) | 1.60 (Distress) | 0.94 (Distress) |
Total debt / equity | 2.32 | 0.42 | 2.63 |
Quick ratio | 0.7x | -0.9x | 4.0x |
Interest coverage | 2.3x | 0.4x | 2.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +2.4% | -2.8% | +9.7% |
Net income growth YoY | +78.7% | +46.6% | -14.6% |
Gross margin (TTM) | 59.9% | 28.9% | 66.2% |
Operating margin (FY) | 51.9% | 4.7% | 61.4% |
FCF margin (FY) | -8.3% | -8.7% | -85.8% |
5. Trailing price performancePrice change over period |
1M return | +0.3% | -14.9% | -10.9% |
3M return | -3.6% | -24.4% | -18.7% |
6M return | +5.7% | -32.1% | -10.7% |
Year to date | +1.5% | -34.3% | -9.9% |
1Y return | +19.7% | -41.3% | -9.9% |
3Y return | +144.5% | -69.4% | +21.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-118.38 -181.1% premium | $10.17 +117.7% upside | $-404.88 -4943.1% premium |
Wall Street consensus target | $178.00 +22.0% · range $165.00–$190.00 | $13.50 +189.1% · range $8.00–$19.00 | — — |
Consensus stance | 96% Buy4% Hold0% Sell | 25% Buy75% Hold0% Sell | — |